Targeted Temperature Management After In-Hospital Cardiac Arrest: An Ancillary Analysis of Targeted Temperature Management for Cardiac Arrest With Nonshockable Rhythm Trial Data
- PMID: 35318006
- DOI: 10.1016/j.chest.2022.02.056
Targeted Temperature Management After In-Hospital Cardiac Arrest: An Ancillary Analysis of Targeted Temperature Management for Cardiac Arrest With Nonshockable Rhythm Trial Data
Abstract
Background: Targeted temperature management (TTM) currently is the only treatment with demonstrated efficacy in attenuating the harmful effects on the brain of ischemia-reperfusion injury after cardiac arrest. However, whether TTM is beneficial in the subset of patients with in-hospital cardiac arrest (IHCA) remains unclear.
Research question: Is TTM at 33 °C associated with better neurological outcomes after IHCA in a nonshockable rhythm compared with targeted normothermia (TN; 37 °C)?
Study design and methods: We performed a post hoc analysis of data from the published Targeted Temperature Management for Cardiac Arrest with Nonshockable Rhythm randomized controlled trial in 584 patients. We included the 159 patients with IHCA; 73 were randomized to 33 °C treatment and 86 were randomized to 37 °C treatment. The primary outcome was survival with a good neurologic outcome (cerebral performance category [CPC] score of 1 or 2) on day 90. Mixed multivariate adjusted logistic regression analysis was performed to determine whether survival with CPC score of 1 or 2 on day 90 was associated with type of temperature management after adjustment on baseline characteristics not balanced by randomization.
Results: Compared with TN for 48 h, hypothermia at 33 °C for 24 h was associated with a higher percentage of patients who were alive with good neurologic outcomes on day 90 (16.4% vs 5.8%; P = .03). Day 90 mortality was not significantly different between the two groups (68.5% vs 76.7%; P = .24). By mixed multivariate analysis adjusted by Cardiac Arrest Hospital Prognosis score and circulatory shock status, hypothermia was associated significantly with good day 90 neurologic outcomes (OR, 2.40 [95% CI, 1.17-13.03]; P = .03).
Interpretation: Hypothermia at 33 °C was associated with better day 90 neurologic outcomes after IHCA in a nonshockable rhythm compared with TN. However, the limited sample size resulted in wide CIs. Further studies of patients after cardiac arrest resulting from any cause, including IHCA, are needed.
Keywords: in-hospital cardiac arrest; moderate therapeutic hypothermia; neurological outcome; nonshockable rhythm.
Copyright © 2022 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.
Comment in
-
We Must Keep Our Cool Regarding the Effect of Therapeutic Hypothermia After In-Hospital Cardiac Arrest.Chest. 2022 Aug;162(2):281-282. doi: 10.1016/j.chest.2022.03.007. Chest. 2022. PMID: 35940648 No abstract available.
Similar articles
-
Therapeutic hypothermia after nonshockable cardiac arrest: the HYPERION multicenter, randomized, controlled, assessor-blinded, superiority trial.Scand J Trauma Resusc Emerg Med. 2015 Mar 7;23:26. doi: 10.1186/s13049-015-0103-5. Scand J Trauma Resusc Emerg Med. 2015. PMID: 25882712 Free PMC article. Clinical Trial.
-
Targeted Temperature Management for Cardiac Arrest with Nonshockable Rhythm.N Engl J Med. 2019 Dec 12;381(24):2327-2337. doi: 10.1056/NEJMoa1906661. Epub 2019 Oct 2. N Engl J Med. 2019. PMID: 31577396 Clinical Trial.
-
Targeted Temperature Management for In-Hospital Cardiac Arrest: 6 Years of Experience.Ther Hypothermia Temp Manag. 2020 Sep;10(3):153-158. doi: 10.1089/ther.2019.0019. Epub 2019 Jul 17. Ther Hypothermia Temp Manag. 2020. PMID: 31314693
-
Survival to hospital discharge and neurological outcomes with targeted temperature management after in-hospital cardiac arrest: a systematic review and meta-analysis.Ann Palliat Med. 2022 Jan;11(1):68-76. doi: 10.21037/apm-21-3403. Ann Palliat Med. 2022. PMID: 35144399
-
Therapeutic hypothermia in patients after cardiac arrest: A systematic review and meta-analysis of randomized controlled trials.Am J Emerg Med. 2023 Sep;71:182-189. doi: 10.1016/j.ajem.2023.06.040. Epub 2023 Jun 28. Am J Emerg Med. 2023. PMID: 37421815
Cited by
-
Temperature control after cardiac arrest.Crit Care. 2022 Nov 24;26(1):361. doi: 10.1186/s13054-022-04238-z. Crit Care. 2022. PMID: 36434649 Free PMC article.
-
The role of targeted temperature management in 30-day hospital readmissions in cardiac arrest survivors: A national population-based study.Int J Cardiol Heart Vasc. 2023 Apr 18;46:101207. doi: 10.1016/j.ijcha.2023.101207. eCollection 2023 Jun. Int J Cardiol Heart Vasc. 2023. PMID: 37113651 Free PMC article.
-
Application of high-quality targeted temperature management guided by multimodal brain monitoring in brain protection of patients with cardiac arrest: A case series.Medicine (Baltimore). 2024 Dec 20;103(51):e40943. doi: 10.1097/MD.0000000000040943. Medicine (Baltimore). 2024. PMID: 39705417 Free PMC article.
-
The association between C-reactive protein to albumin ratio and 6-month neurological outcome in patients with in-hospital cardiac arrest.World J Emerg Med. 2024;15(3):223-228. doi: 10.5847/wjem.j.1920-8642.2024.037. World J Emerg Med. 2024. PMID: 38855379 Free PMC article. No abstract available.
-
Temperature control in adults after cardiac arrest: a survey of current clinical practice in Germany.Crit Care. 2023 Jan 23;27(1):35. doi: 10.1186/s13054-023-04319-7. Crit Care. 2023. PMID: 36691075 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical